Tag: Opposition

Etanercept applications granted by IPO

The Assistant Controller of Patents and Designs on 7 November 2016 allowed two applications of Pfizer Ireland covering their commercial method for production of Etanercept, dismissing four pre-grant oppositions.
Read More

The Nightmare of Section 8

Due in part to its often-ambiguous requirements, Section 8 of India’s Patents Act has become a nightmare for patent owners, explains Pravin Anand. The 2009 Chemtura decision of
Read More

Lessons from the Valcyte patent battle

Archana Shanker and Nupur Maithani consider what the battle over the Valcyte patent reveals about the Indian judiciary’s approach to pharmaceutical patents. The Valcyte patent has followed a
Read More